ESC Premium Access

Discussion and live Q&A.

Topic: Pharmacotherapy
Sponsored by AstraZeneca

Congress Session

3 more presentations in this session

Welcome and introduction.

Speaker: Professor C. Lam (Singapore, SG)

Thumbnail

Emerging evidence for SGLT2i in HFrEF patients.

Speaker: Doctor P. Kumar Sahoo (Bhubaneswar, IN)

Thumbnail

SGLT2i in ESC 2021 HF management guideline - clinical implication.

Speaker: Doctor J. Kang (Seoul, KR)

Thumbnail

Access the full session

Evolving role of SGLT2i in HFrEF management

Speakers: Professor C. Lam, Doctor P. Kumar Sahoo, Doctor J. Kang
Thumbnail

About the event

Image

ESC Asia with APSC & AFC 2021

2 December - 4 December 2021

Sessions Presentations

Related content

Open Access

Advanced and acute heart failure.

27 August 2021

Open Access

Classification of HF and diagnosis and treatment of HFmrEF and HFpEF.

27 August 2021

Open Access

New recommendations for the treatment of HFrEF.

27 August 2021

This platform is supported by

logo Novo Nordisk